data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
vTv Therapeutics
(NASDAQ:VTVT)
0.79
0.0404[5.39%]
At close: Jun 27
0.7795
-0.0105[-1.33%]
After Hours: 4:08PM EDT
Day High/Low0.74 - 0.8
52 Week High/Low0.38 - 2.48
Open / Close0.79 / 0.79
Float / Outstanding40.7M / 77.3M
Vol / Avg.151.7K / 869.6K
Mkt Cap61.1M
P/E-
50d Avg. Price0.63
Div / Yield-
Payout Ratio-
EPS-0.1
Total Float40.7M

vTv Therapeutics (NASDAQ:VTVT), Quotes and News Summary

vTv Therapeutics (NASDAQ: VTVT)

Day High/Low0.74 - 0.8
52 Week High/Low0.38 - 2.48
Open / Close0.79 / 0.79
Float / Outstanding40.7M / 77.3M
Vol / Avg.151.7K / 869.6K
Mkt Cap61.1M
P/E-
50d Avg. Price0.63
Div / Yield-
Payout Ratio-
EPS-0.1
Total Float40.7M
Benzinga - Jun 7, 2022, 10:49AM
Benzinga - Jun 3, 2022, 7:05AM
Benzinga - Jun 1, 2022, 8:51AM
Benzinga - Jun 1, 2022, 6:56AM
Benzinga - May 12, 2022, 7:46AM
Benzinga - May 12, 2022, 6:17AM
Benzinga - Mar 29, 2022, 5:34PM
Benzinga - Mar 3, 2022, 5:28PM
Benzinga - Feb 18, 2022, 10:51AM
Benzinga - Feb 18, 2022, 6:43AM
Benzinga - Jan 13, 2022, 8:40AM
Benzinga - Dec 7, 2021, 5:43AM
Benzinga - Dec 6, 2021, 5:21PM
load more
Sector: Health Care.Industry: Biotechnology
vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-0.080-0.100 -0.0200
REV2.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

vTv Therapeutics Questions & Answers

Q
How do I buy vTv Therapeutics (VTVT) stock?
A

You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are vTv Therapeutics's (VTVT) competitors?
Q
What is the target price for vTv Therapeutics (VTVT) stock?
A

The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by Cantor Fitzgerald on Friday, February 18, 2022. The analyst firm set a price target for 5.00 expecting VTVT to rise to within 12 months (a possible 532.91% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for vTv Therapeutics (VTVT)?
A

The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.79 last updated June 27, 2022, 8:00 PM UTC.

Q
Does vTv Therapeutics (VTVT) pay a dividend?
A

There are no upcoming dividends for vTv Therapeutics.

Q
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
A

vTv Therapeutics’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is vTv Therapeutics (VTVT) going to split?
A

There is no upcoming split for vTv Therapeutics.

Q
What sector and industry does vTv Therapeutics (VTVT) operate in?
A

vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.